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structure of Hsp90 homologs in solution
(Bron et al., 2008). In their study, apo-
Hsp90 is shown to be in a conformational
equilibrium between two open states sim-
ilar to the open state observed for apo-
HtpG in Krukenberg et al. (2008). By com-
paring the cryo-EM maps with known
crystal structures, the structural changes
involved in switching between the two
apo conformations are shown to require
large movements of both the N-terminal
domain and the middle domain around
two flexible hinge regions similar to the
rigid-body motions of the middle domain
relative to both the N-terminal and C-ter-
minal domains required in the study on
HtpG. Both studies are reminiscent of
results from an H/D mass spectrometry
study on human Hsp90 in solution, which
showed that cochaperone and inhibitor
binding to the N-terminal domain induced
conformational changes in both domain-
domain interfaces (Phillips et al., 2007).
Krukenberg et al. (2008), along with
other studies on Hsp90 in solution, con-
tributes to providing strong evidence
that this protein has a highly dynamic
structure and that it can adopt a number
of conformations in solution, which might
not necessarily be similar to those seen in
the crystalline form. This work illustrates
the importance of combining solution
studies with high-resolution structures.
Having established the value of SAXS
techniques to probe the conformation of
Hsp90 homologs in solution (Bron et al.,
2008; Krukenberg et al., 2008), these
methods will almost certainly prove to be
valuable in elucidating the structures of
larger Hsp90-cochaperone complexes
and hopefully ultimately the structure of
a client protein bound to the Hsp90 as-
sembly machine. Indeed SAXS has al-
ready been used very effectively on the
complex formed between Hsp90 and the
cochaperone Hop (Onuoha et al., 2008).
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In this issue of Structure, Boczkowska et al. (2008) investigate the activation of the Arp2/3 complex and
propose a provocative model for Arp2/3-dependent filament formation.Eukaryotic cells must solve a difficult
problem: how to establish and maintain
order across cellular dimensions (typically
10–100 microns) using molecules that are
several orders of magnitude smaller (typi-
cally 1–20 nanometers). They do this, in
part, by assembling molecules into net-
works of cytoskeletal polymers. Networks
of crosslinked actin filaments, for exam-
ple, control the shape and mechanical
properties of most cells and enable them
to move. Considerable work has gone
into understanding the structure and
assembly of these cytoskeletal polymersand we know a lot about how pre-existing
polymers elongate. We do not understand
nearly so well, however, how new
polymers are formed from monomeric
precursors. In the particular case of actin,
the nucleation of new filaments, whether
spontaneous or initiated by regulatory
factors, is slow compared to filament
elongation. Nucleation intermediates are,
therefore, rare and short lived. These
properties make them poor candidates
for structural studies, which generally
require large quantities of stable and
homogeneous species.Structure 16, May 200This problem confronted structural
biologist Roberto Dominguez and his
colleagues (Boczkowskaet al., 2008),who
wanted to understand how one important
nucleator, the Arp2/3 complex, generates
new actin filaments. To understand the
specific questions these authors address
requires a brief discussion how actin
filaments form spontaneously, in the ab-
sence of a nucleation factor. An actin fila-
ment can be described as a two-stranded
(two-start), right-handed helix. To move
from one monomer to the next along one
strandof thefilament requiresa translation8 ª2008 Elsevier Ltd All rights reserved 661
Structure
Previewsof 5.5 nm and a clockwise rotation of ap-
proximately 26 around the filament axis.
Each monomer in a filament makes con-
tact with four others—two in the same
strand and two in the opposing strand
(Figure 1, top). The best information on
spontaneous actin assembly comes from
analysis of in vitro polymerization kinetics
and frommolecular dynamics simulations
of actin monomer interactions. Kinetic
analysis indicates that the actin filament
nucleus, the smallest oligomer more likely
to elongate than fall apart, is composed
of three monomers (Kasai et al., 1962;
Frieden, 1983). Based on thermodynamic
considerations and molecular dynamics
simulations, the monomers in this trimer
are probably arranged in a configuration
where each makes contact with the other
two (Sept and McCammon, 2001). The
only way to achieve this configuration is
for two of the monomers to belong to
one helical strand while the third belongs
to the opposing strand (Figure 1, bottom).
The Arp2/3 complex contains two actin
related proteins (ARPs) that are thought to
combine with a conventional actin mono-
mer to form a trimeric filament nucleus
(Welch and Mullins, 2002). To generate
this structure the complex must bind to
the side of a pre-existing filament and in-
teract with an actin monomer bound to
a nucleation promoting factor (Figure 2).
Nucleation promoting factors include
members of theWASP/Scar family of pro-
teins and contain an Arp2/3-activating
domain called a WCA (or VCA) domain.
This domain is composed of three parts:
an actin-binding WH2 domain (W), a cen-
tral or connecting helix (C), and an acidic,
Arp2/3-binding domain (A). Previous work
has shown that the VCA domain induces
a conformational change in the Arp2/3
complex and, via its WH2 domain, posi-
tions the first actin monomer onto the
complex. The question Boczkowska et al.
asked is: howexactly does this firstmono-
mer interact with the complex? Do the
Arps and the actin form a trimer similar
to the one thought to underlie spontane-
ous actin polymerization? Based on the
relative positions and orientations of
Arp2 and Arp3 in the complex (Robinson
et al., 2001; Rouiller et al., 2008) the only
way to form such a trimer would be for
the actin monomer to interact with the
so-called ‘‘barbed end’’ of the Arp3
subunit (Figure 2, Model 1). Interaction
with the analogous surface on Arp2 would662 Structure 16, May 2008 ª2008 Elsevierpreclude formation of the heterotrimer
(Figure 2, Model 2).
To overcome the fugitive nature of the
Arp2/3-VCA-actinnucleation intermediate,
Boczkowska et al. developed a strategy
for simultaneously preventing both com-
plex dissociation and filament formation.
To stabilize the nucleation complex, they
covalently crosslinked the WH2 region
of N-WASP VCA to an actin monomer.
This crosslinked species binds the Arp2/3
complex with higher affinity than either
monomeric actin or the VCAdomain alone
and, because the WH2 domain binds
a face of actin involved in polymerization,
crosslinking has the added benefit of sup-
pressing filament formation. To determine
the structure of this potential nucleation
intermediate the authors used small angle
X-ray scattering (SAXS). Like NMR, SAXS
is useful for studying structures of macro-
molecules in solution. Its advantages in-
clude the fact that it requires much lower
protein concentrations andcangive useful
information about very large protein com-
plexes whose atomic structures would be
Figure 1. Monomer-Monomer Interactions
in an Actin Filament
Top: Two-stranded arrangement of an actin fila-
ment. The right-handed helical twist of the filament
has been removed to better illustrate the inter- and
intrastrand contacts. The fast-growing, barbed
end of the filament is marked ‘‘+’’. The slow-grow-
ing, pointed end ismarked ‘‘’’. Bound nucleotides
are represented by ‘‘T’’ (ATP) or ‘‘D’’ (ADP).
Middle: Each monomer in the filament interacts
with two adjacent monomers in the same strand
and two monomers in the opposing strand.
Bottom: Two actin trimers making contacts analo-
gous to those found in a filament. The bottom
trimer is thought to represent the main nucleation
intermediate involved in spontaneous assembly
of new actin filaments.Ltd All rights reserveddifficult to solve by NMR. Its major disad-
vantage is, of course, low resolution. The
resolution of the technique is, however,
sufficient to test candidate models for
the interaction of the Arp2/3 complex
with a WH2-bound actin monomer. Using
previously determined crystal structures
of actin and the unactivated Arp2/3 com-
plex (Robinson et al., 2001), Boczkowska
et al. constructed three-dimensional
models consistent with two modes of
actin:Arp2/3 interaction—actin bound to
the barbed end of Arp3 and actin bound
to the barbed endof Arp2. They compared
X-ray scattering curves calculated from
the models with data obtained from the
crosslinked complex. In addition, they
docked the model structures into the
three-dimensional envelope calculated
from the scattering data. Both methods
yielded a surprising result: models with
the actin monomer at the barbed end of
Arp3 do not fit their data as well asmodels
inwhich theactin interactswith thebarbed
end of Arp2 (Figure 2, Model 2).
One obvious caveat to this work is that
the Dominguez group could not perform
X-ray scattering in the presence of fila-
mentous actin, a cofactor essential for
full activation of the Arp2/3 complex. As
a result, it is possible that their models
do not reflect the conformation of a pro-
ductive nucleation intermediate. Never-
theless, this work represents the state of
the art in our understanding of the activa-
tion of the Arp2/3 complex and provides
a provocative model for Arp2/3-depen-
dent filament formation. The configuration
of Arp2 and actin in Dominguez’s model is
analogous to the interaction between two
actin monomers in the same filament
strand. Interestingly, this is the same con-
figuration promoted by several recently
discovered actin nucleation factors, in-
cluding Spire, cordonbleu (Cobl), and the
pathogen-encoded protein VopL (Quinlan
and Kerkhoff, 2008). All of these proteins
use tandemWH2 domains to align mono-
mers into a configuration similar to a single
strand of an actin filament. Looking at the
sequence of the C region of the VCA do-
main, Dominguez and colleagues notice
a possible similarity to the WH2 domain.
From this similarity and their structural
models these authors propose that the C
domain binds Arp2 in amanner analogous
to the way in which the WH2 binds actin
and that the WH2 and C regions stitch
actin and Arp2 together in a manner
Structure
PreviewsFigure 2. Mechanism of Arp2/3-Dependent Filament Formation
Left: To form a new (daughter) filament (far right), the Arp2/3 complex must interact with a pre-existing
(mother) filament, the WCA domain from a nucleation promoting factor (usually a WASP-family protein),
and an actin monomer. Right: Two possible modes of interaction between actin:WCA and the Arp2/3
complex. The actin monomer could be positioned onto the barbed (fast-growing) end of Arp3 (top) or
onto the barbed end of Arp2 (bottom). Work from the Dominguez group (Boczkowska et al., 2008) favors
the bottom model.similar to theway Spire-like proteins stitch
together conventional actin monomers.
From this, the Dominguez group specu-
lates that Arp2/3 complex-dependent
nucleation may have arisen from a Spire-
like, tandem WH2-mediated mechanism
and that the additional, non-Arp subunits
in the complex may have evolved later to
anchor the newly formed filament to the
side of a pre-existing filament to form a
crosslinked array. Given that the Arp2/3
complex is conserved across eukaryotic
phyla, while nucleators using tandem
WH2 domains appear only in Metazoa, itseems more likely that Arp2/3-dependent
nucleation is the more ancient.
The Dominguez model begs an obvious
question: Why not tether the WH2-bound
monomer to the barbed end of Arp3?
Naively, this configuration appears more
stable since the actin could interact with
both Arps. One possible answer comes
from thinking about how the next actin
monomer (after the one bound to the
WH2 domain) will interact with this struc-
ture. If the WH2-bound monomer were
positioned on the barbed end of Arp3,
the next monomer could interact onlyStructure 16, May 200with it and with Arp2 (Figure 2, Model 1).
In the Dominguez model, the next mono-
mer can simultaneously interact with
Arp2, Arp3, and the tethered monomer.
In other words, instead of creating a struc-
ture with an affinity for actin monomers
similar to an actin filament, the Arp2/
3:WCA:actin complex creates a structure
with a higher affinity. This higher affinity
might decrease the rate of monomer dis-
sociation and increase the efficiency of
the nucleation reaction. The nucleation in-
termediate proposed by Dominguez may,
therefore, represent a carefully laid trap,
designed to more efficiently snare actin
monomers.
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